# Eye Health America

Eye Health America is an Eye Care Services based in Easley, United States.

## Overview

- **Organization type:** Eye Care Services
- **Headquarters:** Easley, United States
- **Region:** North America
- **Address:** Easley, SC, United States
- **Founded:** 2018
- **Assets under management:** Undisclosed
- **Website:** eyehealthamerica.com
- **LinkedIn:** https://www.linkedin.com/company/eye-health-america

## Regulatory record

- **Reports private funds:** No

## About

Eye Health America formed in 2018 when Dallas-based private equity firm Latticework Capital partnered with CEO Rod Roeser to acquire and integrate ophthalmology and optometry practices. The platform targets the Southeastern US, where demographic tailwinds — an aging population with high cataract and glaucoma incidence — support sustained procedure volume. The firm does not disclose its total deployment or asset base. Eye Health America acquires majority stakes in established practices, leaving clinical and operational physicians with meaningful minority ownership. It covers comprehensive ophthalmology, cataract surgery, glaucoma treatment, retina care, and optical retail. The firm's model adds shared back-office functions — billing, HR, IT, marketing — while physicians retain autonomy over medical decisions. Known affiliate practices have included The Eye Associates in Bradenton, Florida, and Clemson Eye in South Carolina, among other regional groups. Latticework Capital, the financial sponsor, manages roughly $345 million across its first fund as of 2018 public records and raised additional commitments for later vintages. Eye Health America represents one of several healthcare-services platforms in Latticework's portfolio. The firm's leadership team blends operational healthcare executives with private equity professionals; Rod Roeser previously held senior roles at ophthalmology and dental services organizations before launching the platform. What distinguishes Eye Health America is its explicit sponsor-backed roll-up architecture rather than a family-office or physician-owned management services organization. This structure aligns Latticework's capital with physician-partners who receive both cash at close and ongoing equity in the platform, a liquidity path that traditional hospital-employed models rarely offer.

## Sectors

- Healthcare Services

## People

- Rod Roeser — Chief Executive Officer

## Questions

### Who runs investment decisions at Eye Health America?

The firm operates as a portfolio company of Latticework Capital, a Dallas-based private equity firm. Strategic acquisition and capital-allocation decisions are made jointly by Eye Health America's CEO, Rod Roeser, and Latticework's investment team. Latticework's managing partners have final authority on platform-level financing and new practice acquisitions.

### Which regions does Eye Health America target for acquisitions?

The firm concentrates exclusively on the Southeastern United States, with known affiliates in South Carolina and Florida. The region's favorable demographics — particularly a high concentration of Medicare-age patients — drive demand for cataract surgery, glaucoma management, and retina care. The firm has not disclosed expansion into other US regions.

### How does Eye Health America source new practice partnerships?

Eye Health America sources through a combination of direct outreach, industry conferences, and broker-sourced practice listings. It recruits practices through its brand promise that physician founders can monetize a portion of their equity while continuing to manage clinical operations. The firm emphasizes a 'doctor-led, business-supported' narrative that competes against hospital systems and other PE-backed consolidators.

### Does Eye Health America make minority investments or only control acquisitions?

Eye Health America pursues majority recapitalizations, acquiring control while offering selling physicians ongoing minority equity in the platform. It does not operate as a passive minority investor. The structure is designed to give physicians liquidity at close plus potential for a second liquidity event when the parent company itself recapitalizes or sells.

## Related profiles

- [CreekStone Capital Management](https://altss.com/profile/creekstone-capital-management)
- [Pivotal bioVenture Partners China](https://altss.com/profile/pivotal-bioventure-partners-china)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/eye-health-america-llc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology